<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Envue Medical, Inc. — News on 6ix</title>
<link>https://6ix.com/company/envue-medical-inc</link>
<description>Latest news and press releases for Envue Medical, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 20 Apr 2026 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/envue-medical-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d7516351cc36e475335901.webp</url>
<title>Envue Medical, Inc.</title>
<link>https://6ix.com/company/envue-medical-inc</link>
</image>
<item>
<title>ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-announces-40th-us-hospital-customer-with-addition-of-a-virginia-medical-center-affiliated-with-the-mayo-clinic-care-network</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-announces-40th-us-hospital-customer-with-addition-of-a-virginia-medical-center-affiliated-with-the-mayo-clinic-care-network</guid>
<pubDate>Mon, 20 Apr 2026 12:30:00 GMT</pubDate>
<description>Regional hospital transitions feeding tube procedures from interventional radiology to bedside nursing care using the ENvue™ Navigation PlatformTYLER, Texas, April 20, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced that a Virginia-based, 255-bed nonprofit regional medi</description>
</item>
<item>
<title>ENvue Medical Expands Presence within a Major Michigan Health System and Grows U.S. Hospital Footprint to 39</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-expands-presence-within-a-major-michigan-health-system-and-grows-us-hospital-footprint-to-39</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-expands-presence-within-a-major-michigan-health-system-and-grows-us-hospital-footprint-to-39</guid>
<pubDate>Tue, 24 Mar 2026 12:07:00 GMT</pubDate>
<description>Premier 714-bed teaching hospital and Level I Trauma Center purchases ENvue™ Navigation Platform system and feeding tubesTYLER, Texas, March 24, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced a purchase of the ENvue™ Navigation Platform and feeding tubes by a premier t</description>
</item>
<item>
<title>ENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal Camera</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-strengthens-patent-portfolio-with-new-uspto-notice-of-allowance-for-feeding-tube-combining-electromagnetic-navigation-with-direct-visualization-through-an-integrated-internal-camera</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-strengthens-patent-portfolio-with-new-uspto-notice-of-allowance-for-feeding-tube-combining-electromagnetic-navigation-with-direct-visualization-through-an-integrated-internal-camera</guid>
<pubDate>Tue, 24 Feb 2026 13:30:00 GMT</pubDate>
<description>Technology supports the evolution of enteral access from blind procedures to real-time visualized placementTYLER, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a leader in advanced navigation technologies for enteral access, today announced that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for the Company’s patent application titled “Feeding Tube with Electromagnetic Sensor and</description>
</item>
<item>
<title>ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-signs-strategic-partnership-agreement-with-u-deliver-for-us-distribution-of-over-the-counter-reusable-enfit-syringe-line</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-signs-strategic-partnership-agreement-with-u-deliver-for-us-distribution-of-over-the-counter-reusable-enfit-syringe-line</guid>
<pubDate>Wed, 28 Jan 2026 14:00:00 GMT</pubDate>
<description>Distribution agreement leverages U-Deliver’s digital and wholesale channels to expand access to ENvue’s recently launched ENFit Syringes across non-acute care channelsTYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the signing of a</description>
</item>
<item>
<title>ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-appoints-industry-veteran-marc-waldman-as-vice-president-commercial</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-appoints-industry-veteran-marc-waldman-as-vice-president-commercial</guid>
<pubDate>Wed, 21 Jan 2026 13:30:00 GMT</pubDate>
<description>Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growthTYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldma</description>
</item>
<item>
<title>ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-launches-over-the-counter-reusable-enfit-syringes-to-support-feeding-and-medication-delivery-without-a-prescription</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-launches-over-the-counter-reusable-enfit-syringes-to-support-feeding-and-medication-delivery-without-a-prescription</guid>
<pubDate>Wed, 14 Jan 2026 13:30:00 GMT</pubDate>
<description>New Product Line Enhances Continuity of Care Across Clinical and Home SettingsTYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a line of over-the-counter ENFit Syringes designed to meet both feeding and medication deliv</description>
</item>
<item>
<title>ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-launches-program-to-address-patient-pain-and-discomfort-with-indwelling-nasogastric-tubes-based-on-previously-published-peer-reviewed-clinical-research</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-launches-program-to-address-patient-pain-and-discomfort-with-indwelling-nasogastric-tubes-based-on-previously-published-peer-reviewed-clinical-research</guid>
<pubDate>Fri, 09 Jan 2026 14:01:00 GMT</pubDate>
<description>The program will integrate the Company’s clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubesTYLER, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing on the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a new development and</description>
</item>
<item>
<title>ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-to-ring-the-nasdaq-opening-bell-on-wednesday-january-14th-2026</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-to-ring-the-nasdaq-opening-bell-on-wednesday-january-14th-2026</guid>
<pubDate>Thu, 08 Jan 2026 15:02:00 GMT</pubDate>
<description>TYLER, Texas, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems including enteral access solutions and non-opioid pain management, today announced the Company will ring the Nasdaq Opening Bell at the Nasdaq MarketSite in Times Square, New York, on Wednesday, January 14, 2026. The ceremony will be led by Doron Besser, MD, Chief Executive Offi</description>
</item>
<item>
<title>ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-formerly-nanovibronix-uroshieldr-kit-secures-reimbursement-in-the-uk</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-formerly-nanovibronix-uroshieldr-kit-secures-reimbursement-in-the-uk</guid>
<pubDate>Thu, 18 Dec 2025 17:30:00 GMT</pubDate>
<description>Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® KitTYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that the UroShield® Kit has been added to the UK National Health Service (NHS) Drug Tariff Part IX, enabli</description>
</item>
<item>
<title>ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medicals-uroshieldr-kit-secures-reimbursement-in-the-uk</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medicals-uroshieldr-kit-secures-reimbursement-in-the-uk</guid>
<pubDate>Thu, 18 Dec 2025 14:00:00 GMT</pubDate>
<description>Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® KitTYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that the UroShield® Kit has been added to the UK National Health Service (NHS) Drug Tariff Part IX, enabling nationwide p</description>
</item>
<item>
<title>ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-appoints-veteran-healthcare-industry-executive-david-johnson-as-chairman</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-appoints-veteran-healthcare-industry-executive-david-johnson-as-chairman</guid>
<pubDate>Mon, 15 Dec 2025 14:00:00 GMT</pubDate>
<description>TYLER, Texas, December 15, 2025--ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced the appointment of David Johnson as Chairman of the Board. Mr. Johnson will work alongside CEO, Doron Besser, and the existing leadership team.</description>
</item>
<item>
<title>ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System</title>
<link>https://6ix.com/company/envue-medical-inc/news/envue-medical-granted-us-patent-for-pediatric-feeding-tube-guidance-system</link>
<guid isPermaLink="true">https://6ix.com/company/envue-medical-inc/news/envue-medical-granted-us-patent-for-pediatric-feeding-tube-guidance-system</guid>
<pubDate>Wed, 11 Jun 2025 04:00:00 GMT</pubDate>
<description>Patent strengthens ENvue’s IP position as it advances toward pediatric regulatory clearance and expanded clinical use TYLER, Texas--(BUSINESS WIRE)--</description>
</item>
</channel>
</rss>